Company Profile (AI Text)
Name: BioSmart Research, Inc.
Canonical URL: https://wefunder.com/biosmart.research.inc
Updated at: 2026-06-22T05:03:15Z

Tagline: BioSmart Research: Invest in the future of cannabinoid therapy.
Elevator pitch: BioSmart Research produces CBD isolate formulas for topical and internal use

Key claims:
- Total raised on Wefunder: 53200 | citation: https://wefunder.com/biosmart.research.inc#claim-total-raised
- Total investors: 21 | citation: https://wefunder.com/biosmart.research.inc#claim-total-investors

Verified facts:
- Total raised on Wefunder: 53200 | observed_at: 2026-06-22T05:03:15Z | expires_at: 2026-06-23T05:03:15Z
- Total investors: 21 | observed_at: 2026-06-22T05:03:15Z | expires_at: 2026-06-23T05:03:15Z

Computed metrics:
- total_amount_raised: 53200
- total_investors: 21
- team_size: 1
- featured_investor_count: 1
- faq_count: 2
- recent_post_count: 0

Quick facts:
- Launch in 2019 produced $1.7M in sales | citation: https://wefunder.com/biosmart.research.inc#claim-fact-1
- Biosmart produces pain management and anti-anxiety formulas for clinical and retail distribution | citation: https://wefunder.com/biosmart.research.inc#claim-fact-2
- BioSmart has a 3-year technology lead using high-pressure liquid chromatography for isolate extraction | citation: https://wefunder.com/biosmart.research.inc#claim-fact-3
- BioSmart markets through it's own retail dispensaries, healthcare providers, pharmacies, affiliates, and internet sales | citation: https://wefunder.com/biosmart.research.inc#claim-fact-4
- U.S. Market for non-steroidal OTC pain relievers is $21.9 B/yr. US CBD market is $4.7 B/yr. | citation: https://wefunder.com/biosmart.research.inc#claim-fact-5
- Clinical dosing levels with CBD isolates produce similar results to OTC pain relievers without the side effects. | citation: https://wefunder.com/biosmart.research.inc#claim-fact-6
- BioSmart collaborates with university and clinical researchers and is a member of Choose Wisely, a patient forum | citation: https://wefunder.com/biosmart.research.inc#claim-fact-7
- BioSmart Research represents a responsible approach to improving quality of life and advancing cannabinoid research | citation: https://wefunder.com/biosmart.research.inc#claim-fact-8

FAQ:
- Q: What you’re doing is interesting, but I have a few questions: 1) If I understand everything correctly, it looks like the bulk of the nearly $1.9M in revenues earned in 2019 came from equipment sales by Washington State Enterprises, Inc. (WSE). Is WSE still a viable entity, and...
  A: 1. WSE is still a viable entity but we are not currently promoting the equipment sales aggressively. Equipment sales involved engineering and on-site set-up and management which were not possible during the covid lock-down. At that time we had already decided to change direction and promote the formulas which were a result of our research. Covid forced us into lock-down giving us time to set up our own labs and manufacturing facilities to produce our formulas. WSE still has approximately $50,...
- Q: What are revenues year-to-date, and did you achieve your goal of being cash-flow positive by the end of summer?
  A: Summers not over yet. We got off to a slow start and had to re-hire and train. I expect that we should be cash-flow positive by November.